House Bill 803
116th Congress(2019-2020)
Improving Transparency and Accuracy in Medicare Part D Spending Act
Introduced
Introduced in House on Jan 25, 2019
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
803
Congress
116
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
Peter Welch
grade
Vermont
Alabama
Alabama
Alabama
Alabama
Arkansas
Arkansas
Arkansas
Georgia
Georgia
Georgia
Georgia
Iowa
Kansas
Kansas
Kentucky
Maine
Maine
Maryland
Maryland
North Carolina
Ohio
Pennsylvania
Tennessee
Texas
Texas
Virginia
Washington
Washington
No House votes have been held for this bill.
Summary
Improving Transparency and Accuracy in Medicare Part D Spending Act
This bill prohibits Medicare prescription drug plan sponsors from retroactively reducing payment on clean claims submitted by pharmacies. (A "clean claim" is a Medicare claim that is free of defects such as incomplete documentation.)
January 25, 2019
Sort by most recent
03/01/2019
Referred to the Subcommittee on Health.
01/28/2019
Referred to the Subcommittee on Health.
01/25/2019
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
01/25/2019
Introduced in House
Public Record
Record Updated
Nov 1, 2022 2:47:38 PM